vs
Bioceres Crop Solutions Corp.（BIOX）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是Bioceres Crop Solutions Corp.的1.2倍（$94.3M vs $77.6M），REPUBLIC BANCORP INC净利率更高（24.2% vs -9.6%，领先33.8%），REPUBLIC BANCORP INC同比增速更快（5.3% vs -16.8%），过去两年Bioceres Crop Solutions Corp.的营收复合增速更高（-8.4% vs -11.5%）
Bioceres Crop Solutions Corp是一家全球农业科技企业，研发并商业化耐旱种子性状、生物肥料、生物农药等可持续作物增产解决方案，服务南美、北美、欧洲及亚太地区的农户，致力于提升作物产量，同时降低农业生产的环境影响。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
BIOX vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.2倍
$77.6M
营收增速更快
RBCAA
高出22.1%
-16.8%
净利率更高
RBCAA
高出33.8%
-9.6%
两年增速更快
BIOX
近两年复合增速
-11.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.6M | $94.3M |
| 净利润 | $-7.4M | $22.8M |
| 毛利率 | 46.8% | — |
| 营业利润率 | 9.3% | 29.3% |
| 净利率 | -9.6% | 24.2% |
| 营收同比 | -16.8% | 5.3% |
| 净利润同比 | -20.2% | 20.0% |
| 每股收益（稀释后） | $-0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIOXRBCAA
| Q4 25 | — | $94.3M | ||
| Q3 25 | $77.6M | $93.5M | ||
| Q2 25 | — | $93.8M | ||
| Q1 25 | $60.6M | $135.8M | ||
| Q4 24 | $98.8M | $89.5M | ||
| Q3 24 | $93.3M | $88.1M | ||
| Q2 24 | — | $86.9M | ||
| Q1 24 | $84.0M | $120.3M |
净利润BIOXRBCAA
| Q4 25 | — | $22.8M | ||
| Q3 25 | $-7.4M | $29.7M | ||
| Q2 25 | — | $31.5M | ||
| Q1 25 | $-1.6M | $47.3M | ||
| Q4 24 | $605.2K | $19.0M | ||
| Q3 24 | $-6.2M | $26.5M | ||
| Q2 24 | — | $25.2M | ||
| Q1 24 | $9.8M | $30.6M |
毛利率BIOXRBCAA
| Q4 25 | — | — | ||
| Q3 25 | 46.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 50.8% | — |
营业利润率BIOXRBCAA
| Q4 25 | — | 29.3% | ||
| Q3 25 | 9.3% | 40.4% | ||
| Q2 25 | — | 43.0% | ||
| Q1 25 | 1.5% | 44.1% | ||
| Q4 24 | 14.5% | 25.8% | ||
| Q3 24 | 2.5% | 38.4% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | 15.7% | 32.2% |
净利率BIOXRBCAA
| Q4 25 | — | 24.2% | ||
| Q3 25 | -9.6% | 31.8% | ||
| Q2 25 | — | 33.5% | ||
| Q1 25 | -2.6% | 34.8% | ||
| Q4 24 | 0.6% | 21.2% | ||
| Q3 24 | -6.6% | 30.1% | ||
| Q2 24 | — | 29.0% | ||
| Q1 24 | 11.6% | 25.4% |
每股收益（稀释后）BIOXRBCAA
| Q4 25 | — | — | ||
| Q3 25 | $-0.12 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $-0.10 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $0.14 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $288.3M | $1.1B |
| 总资产 | $734.9M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BIOXRBCAA
| Q4 25 | — | $220.0M | ||
| Q3 25 | $15.5M | $484.2M | ||
| Q2 25 | — | $484.8M | ||
| Q1 25 | $38.5M | $793.0M | ||
| Q4 24 | $29.2M | $432.2M | ||
| Q3 24 | $32.3M | $530.9M | ||
| Q2 24 | — | $400.1M | ||
| Q1 24 | $16.4M | $546.4M |
股东权益BIOXRBCAA
| Q4 25 | — | $1.1B | ||
| Q3 25 | $288.3M | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | $345.0M | $1.0B | ||
| Q4 24 | $346.3M | $992.0M | ||
| Q3 24 | $346.0M | $979.7M | ||
| Q2 24 | — | $955.4M | ||
| Q1 24 | $348.5M | $935.6M |
总资产BIOXRBCAA
| Q4 25 | — | $7.0B | ||
| Q3 25 | $734.9M | $7.0B | ||
| Q2 25 | — | $7.0B | ||
| Q1 25 | $798.2M | $7.1B | ||
| Q4 24 | $835.2M | $6.8B | ||
| Q3 24 | $827.3M | $6.7B | ||
| Q2 24 | — | $6.6B | ||
| Q1 24 | $836.1M | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | — | $161.1M |
| 自由现金流率自由现金流/营收 | — | 170.9% |
| 资本支出强度资本支出/营收 | — | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流BIOXRBCAA
| Q4 25 | — | $168.2M | ||
| Q3 25 | $14.4M | $33.3M | ||
| Q2 25 | — | $8.4M | ||
| Q1 25 | $23.3M | $93.2M | ||
| Q4 24 | $-5.4M | $149.0M | ||
| Q3 24 | $5.2M | $51.3M | ||
| Q2 24 | — | $4.0M | ||
| Q1 24 | $-17.4M | $71.2M |
自由现金流BIOXRBCAA
| Q4 25 | — | $161.1M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | — | $5.2M | ||
| Q1 25 | — | $91.6M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | — | $49.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率BIOXRBCAA
| Q4 25 | — | 170.9% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 67.4% | ||
| Q4 24 | — | 160.0% | ||
| Q3 24 | — | 56.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度BIOXRBCAA
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.7% |
现金转化率BIOXRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | -8.85× | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | -1.78× | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
